These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 23131031)
1. Correlates between host and viral transcriptional program associated with different oncolytic vaccinia virus isolates. Reinboth J; Ascierto ML; Chen NG; Zhang Q; Yu YA; Aguilar RJ; Carretero R; Worschech A; Zhao Y; Wang E; Marincola FM; Szalay AA Hum Gene Ther Methods; 2012 Oct; 23(5):285-96. PubMed ID: 23131031 [TBL] [Abstract][Full Text] [Related]
2. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice. Chen NG; Yu YA; Zhang Q; Szalay AA J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588 [TBL] [Abstract][Full Text] [Related]
3. Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68. Ascierto ML; Worschech A; Yu Z; Adams S; Reinboth J; Chen NG; Pos Z; Roychoudhuri R; Di Pasquale G; Bedognetti D; Uccellini L; Rossano F; Ascierto PA; Stroncek DF; Restifo NP; Wang E; Szalay AA; Marincola FM BMC Cancer; 2011 Oct; 11():451. PubMed ID: 22011439 [TBL] [Abstract][Full Text] [Related]
4. Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus. Haddad D; Chen NG; Zhang Q; Chen CH; Yu YA; Gonzalez L; Carpenter SG; Carson J; Au J; Mittra A; Gonen M; Zanzonico PB; Fong Y; Szalay AA J Transl Med; 2011 Mar; 9():36. PubMed ID: 21453532 [TBL] [Abstract][Full Text] [Related]
5. JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase. Hu W; Hofstetter W; Guo W; Li H; Pataer A; Peng HH; Guo ZS; Bartlett DL; Lin A; Swisher SG; Fang B Cancer Gene Ther; 2008 Sep; 15(9):616-24. PubMed ID: 18535619 [TBL] [Abstract][Full Text] [Related]
6. Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection. Weibel S; Raab V; Yu YA; Worschech A; Wang E; Marincola FM; Szalay AA BMC Cancer; 2011 Feb; 11():68. PubMed ID: 21320309 [TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68. Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320 [TBL] [Abstract][Full Text] [Related]
8. Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68. Gentschev I; Müller M; Adelfinger M; Weibel S; Grummt F; Zimmermann M; Bitzer M; Heisig M; Zhang Q; Yu YA; Chen NG; Stritzker J; Lauer UM; Szalay AA PLoS One; 2011; 6(7):e22069. PubMed ID: 21779374 [TBL] [Abstract][Full Text] [Related]
9. A loss of function analysis of host factors influencing Vaccinia virus replication by RNA interference. Beard PM; Griffiths SJ; Gonzalez O; Haga IR; Pechenick Jowers T; Reynolds DK; Wildenhain J; Tekotte H; Auer M; Tyers M; Ghazal P; Zimmer R; Haas J PLoS One; 2014; 9(6):e98431. PubMed ID: 24901222 [TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcoma. Gentschev I; Adelfinger M; Josupeit R; Rudolph S; Ehrig K; Donat U; Weibel S; Chen NG; Yu YA; Zhang Q; Heisig M; Thamm D; Stritzker J; Macneill A; Szalay AA PLoS One; 2012; 7(5):e37239. PubMed ID: 22615950 [TBL] [Abstract][Full Text] [Related]
11. Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps. Kober C; Rohn S; Weibel S; Geissinger U; Chen NG; Szalay AA J Transl Med; 2015 Jul; 13():216. PubMed ID: 26149494 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic-dependent expression of early transcription factor subunits leads to stringent control of vaccinia virus replication. Hagen CJ; Titong A; Sarnoski EA; Verardi PH Virus Res; 2014 Mar; 181():43-52. PubMed ID: 24394294 [TBL] [Abstract][Full Text] [Related]
14. Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68. Gentschev I; Donat U; Hofmann E; Weibel S; Adelfinger M; Raab V; Heisig M; Chen N; Yu YA; Stritzker J; Szalay AA J Biomed Biotechnol; 2010; 2010():489759. PubMed ID: 20379368 [TBL] [Abstract][Full Text] [Related]
15. The Host Factor Early Growth Response Gene (EGR-1) Regulates Vaccinia virus Infectivity during Infection of Starved Mouse Cells. de Oliveira LC; Brasil BSAF; Unger B; Trindade GS; Abrahão JS; Kroon EG; Traktman P; Bonjardim CA Viruses; 2018 Mar; 10(4):. PubMed ID: 29561772 [TBL] [Abstract][Full Text] [Related]
16. Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus. Zhang Q; Yu YA; Wang E; Chen N; Danner RL; Munson PJ; Marincola FM; Szalay AA Cancer Res; 2007 Oct; 67(20):10038-46. PubMed ID: 17942938 [TBL] [Abstract][Full Text] [Related]
17. Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells. Wang H; Chen NG; Minev BR; Szalay AA J Transl Med; 2012 Aug; 10():167. PubMed ID: 22901246 [TBL] [Abstract][Full Text] [Related]
19. The Vaccinia Virus (VACV) B1 and Cellular VRK2 Kinases Promote VACV Replication Factory Formation through Phosphorylation-Dependent Inhibition of VACV B12. Rico AB; Wang Z; Olson AT; Linville AC; Bullard BL; Weaver EA; Jones C; Wiebe MS J Virol; 2019 Oct; 93(20):. PubMed ID: 31341052 [TBL] [Abstract][Full Text] [Related]
20. Vaccinia virus GLV-1h237 carrying a Walker A motif mutation of mouse Cdc6 protein enhances human breast tumor therapy in mouse xenografts. Hofmann E; Grummt F; Szalay AA Int J Oncol; 2011 Mar; 38(3):871-8. PubMed ID: 21249314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]